摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(2,5-dichloro-4-hydroxyphenoxy)-2-methylpropanoate | 868702-14-1

中文名称
——
中文别名
——
英文名称
methyl 2-(2,5-dichloro-4-hydroxyphenoxy)-2-methylpropanoate
英文别名
2-(2,5-dichloro-4-hydroxy-phenoxy)-2-methyl-propionic acid methyl ester
methyl 2-(2,5-dichloro-4-hydroxyphenoxy)-2-methylpropanoate化学式
CAS
868702-14-1
化学式
C11H12Cl2O4
mdl
——
分子量
279.12
InChiKey
ZRCIHDKGRVKYSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 2-(2,5-dichloro-4-hydroxyphenoxy)-2-methylpropanoatemethanesulfonic acid 5-(4-trifluoromethoxy-phenyl)-pent-4-ynyl ester乙腈 为溶剂, 反应 3.0h, 生成 2-{2,5-dichloro-4-[5-(4-trifluoromethoxy-phenyl)-pent-4-ynyloxy]-phenoxy}-2-methyl-propionic acid methyl ester
    参考文献:
    名称:
    Phenyl derivatives comprising an acetylene group
    摘要:
    这项发明涉及公式I的化合物:其中R5、R6和R7中的一个是氢,X1、X2、R1至R12、m、n和o的定义如描述中所述,以及其药学上可接受的盐和/或酯。此发明还涉及含有这种化合物的制药组合物,制备它们的方法以及它们用于调节PPARδ和/或PPARα激动剂引起的疾病的治疗和/或预防的用途。
    公开号:
    US20060004091A1
  • 作为产物:
    描述:
    甲醇benzoic acid 2,5-dichloro-4-(1-ethoxycarbonyl-1-methyl-ethoxy)-phenyl estersodium盐酸 作用下, 以 甲醇 为溶剂, 反应 4.08h, 以62%的产率得到methyl 2-(2,5-dichloro-4-hydroxyphenoxy)-2-methylpropanoate
    参考文献:
    名称:
    Pyrazole phenyl derivatives
    摘要:
    该发明涉及以下式I的化合物:其中R5、R6和R7中的一个是X1、X2、R1至R15和n如描述中所定义的,以及其药用可接受的盐和/或酯。该发明还涉及含有这些化合物的药物组合物,以及用于治疗和/或预防由PPAR δ和/或PPARα激动剂调节的疾病的用途的方法。
    公开号:
    US20050245589A1
点击查看最新优质反应信息

文献信息

  • Pyrazole Phenyl Derivatives
    申请人:Ackermann Jean
    公开号:US20100035953A1
    公开(公告)日:2010-02-11
    The invention relates to compounds of the formula I: wherein one of R 5 , R 6 and R 7 is and X 1 , X 2 , R 1 to R 15 and n are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPAR δ and/or PPARα agonists.
    本发明涉及公式I的化合物:其中R5、R6和R7中的一个是氢,X1、X2、R1至R15和n如描述中所定义,并且其药学上可接受的盐和/或酯。本发明还涉及含有这种化合物的药物组合物,制备这种化合物的方法以及它们用于治疗和/或预防由PPARδ和/或PPARα激动剂调节的疾病的用途。
  • PYRAZOLE PHENYL DERIVATIVES
    申请人:Ackermann Jean
    公开号:US20110237640A1
    公开(公告)日:2011-09-29
    The invention relates to compounds of the formula I: wherein one of R 5 , R 6 and R 7 is and X 1 , X 2 , R 1 to R 15 and n are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPAR δ and/or PPARα agonists.
    本发明涉及公式I的化合物:其中R5、R6和R7中的一个是,X1、X2、R1至R15和n的定义如描述中所述,并且其药学上可接受的盐和/或酯。本发明还涉及含有这种化合物的制药组合物,它们的制备方法以及它们用于治疗和/或预防由PPAR δ和/或PPARα激动剂调节的疾病的用途。
  • Quantification of the Ambident Electrophilicities of Halogen-Substituted Quinones
    作者:Xingwei Guo、Herbert Mayr
    DOI:10.1021/ja505613b
    日期:2014.8.13
    Kinetics and mechanisms of the reactions of p-quinone, 2,5-dichloro-p-quinone, 2,3,4,5-tetrachloro-p-quinone (chloranil), 2,3,4,5-tetrafluoro-p-quinone (fluoranil), and 3,4,5,6-tetrachloro-o-quinone with pi-nudeophiles (siloxyalkenes, enamines) and amines have been investigated. Products arising from nudeophilic attack at all conceivable sites, that is, at C and O of the carbonyl groups (pathways a, b) as well as at halogenated and nonhalogenated conjugate positions (pathways c, d), were observed. The partial rate constants for the C-attack pathways (a, c, d), which are derived from the photometrically determined second-order rate constants and the product ratios followed the linear free energy relationship log k (20 degrees C) = s(N)(E + (Mayr, H.; et al. J. Am. Chem. Soc. 2001, 123, 9500-9512). It was, therefore, possible to calculate the electrophilicity parameters E of the different positions of the quinones from log k (20 degrees C) and the N and s(N) parameters of the nucleophilic reaction partners, which have previously been derived from their reactions with benzhydrylium ions. Almost all rate constants for the C-attack pathways (a, c, d) were considerably larger than those calculated for the corresponding SET processes, indicating the operation of polar mechanisms. SET mechanisms may only account for the formation of the products formed via O-attack. With the E parameters determined in this work, it is now possible to predict rate constants for the reactions of these quinones with a large variety of nudeophiles and, thus, envisage unprecedented reactions of quinones.
  • PYRAZOLE PHENYL DERIVATIVES AS PPAR ACTIVATORS
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1742923A1
    公开(公告)日:2007-01-17
  • PHENYL DERIVATIVES COMPRISING AN ACETYLENE GROUP
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1765760A1
    公开(公告)日:2007-03-28
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫